A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure
Related Posts
Giri K, Glassock RJ, Fervenza FC. Response to the Letter to the Editor Entitled "Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy". Kidney Int[...]
Moritz ML, Ciapponi A, Hsu CY, Nigwekar SU, Singhal AB, Rhee CM, Kalantar-Zadeh K, Waikar S, Kovesdy CP, Ayus JC. Hyponatremia treatment guidelines: a necessary[...]
Rastogi A, Magay Y, Kady Y. The Alternative Complement Pathway in IgA Nephropathy: A Podcast for Advanced Practice Providers. Adv Ther. 2026 Jul 30. doi:[...]